Key developments: mRNA vaccines and therapeutics
EPR summarises results from key mRNA vaccine trials, highlighting the…
EPR summarises results from key mRNA vaccine trials, highlighting the future potential of these innovative therapeutics.
List view / Grid view
EPR summarises results from key mRNA vaccine trials, highlighting the…
EPR summarises results from key mRNA vaccine trials, highlighting the future potential of these innovative therapeutics.
OTX-2002, a programmable epigenetic medicine is the first mRNA therapy…
OTX-2002, a programmable epigenetic medicine is the first mRNA therapy to target MYC dysregulation and could treat hepatocellular carcinoma.